Showing results (1611-1620 of 12,122) with videos related to
Sort By:
Pageof 1,213
Neuropharmacology|December 1, 1983
On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and beta-carboline derivativesE Costa, M G Corda, A GuidottiNeuropharmacology|February 1, 1984
Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspectsF SulserNeuropharmacology|July 1, 1984
Monoamine activation and enkephalin inhibition of adenylate cyclase in dorsal and ventral striatum of the rabbitB C Christie-Pope, G C Palmer, R B ChronisterNeuropharmacology|May 3, 2002
Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptorsJohannes J Krupp, Bryce Vissel, Christopher G Thomas, et al.Neuropharmacology|May 3, 2002
CGP 44532, a GABAB receptor agonist, is hedonically neutral and reduces cocaine-induced enhancement of rewardV Dobrovitsky, P Pimentel, A Duarte, et al.Neuropharmacology|May 3, 2002
Phenotypic resolution of spontaneous and D1-like agonist-induced orofacial movement topographies in congenic dopamine D1A receptor 'knockout' miceK Tomiyama, F N McNamara, J J Clifford, et al.Neuropharmacology|May 3, 2002
Inhibition of skeletal muscle nicotinic receptors by the atypical antipsychotic clozapineQ-T Nguyen, R MilediNeuropharmacology|May 3, 2002
Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissueL-P Zou, N Abbas, I Volkmann, et al.Neuropharmacology|October 1, 1994
m-sulphonate benzene diazonium chloride: a novel GABAA receptor antagonistB J Krishek, X Xie, M J Bouchet, et al.Neuropharmacology|October 1, 1994
FR139317, a specific ETA-receptor antagonist, inhibits cerebral activation by intraventricular endothelin-1 in conscious ratsP M Gross, D F Weaver, L T Ho, et al.Pageof 1,213